Urinary thrombomodulin in patients with rheumatoid arthritis: Relationship to disease subset

Clinical Rheumatology

Volumn 18, Issue 5, 1999, Pages 385-389

  Hanyu, Tadamasa ^a   Aral, K ^a   Nakano, M ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b MITSUBISHI GAS CHEMICAL COMPANY INC   (Japan)

Author keywords

Rheumatoid arthritis; Thrombomodulin; Urine; Vasculitis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; THROMBOMODULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE;

EID: 0032881162     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050123     Document Type: Article

References (19)

1. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987;235:1348-52.
2. Owen WG, Esmon CT. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1981;256:5532-5.
3. Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 1985;82:1121-5.
4. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985;76:2178-81.
5. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991;65:618-23.
6. Conway EM, Nowakowski B, Steiner-Mosonyi M. Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. Blood 1992;80:1254-63.
7. McCachren SS, Diggs J, Weinberg JB, Dittman WA. Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages. Blood 1991;78:3128-32.
8. Conway EM, Nowakowski B. Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis. Blood 1993;81:726-33.
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Ishii H, Nakano M, Tsubouchi J, Ishikawa T, Uchiyama H, Hiraishi S, et al. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemost 1990;60:157-62.
11. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
12. Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Arthritis Rheum 1971;14:706-20.
13. Fries JF, Bloch DA, Sharp JT, McShane DJ, Spitz P, Bluhm GB, et al. Assessment of radiologic progression in rheumatoid arthritis: A randomized, controlled trial, Arthritis Rheum 1986;29:1-9.
14. Ochi T, Iwase R, Yonemasu K, Matsukawa M, Yoneda M, Yukioka M, Ono K. Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis. Arthritis Rheum 1988;31:37-43.
15. Kawakami M, Kitani A, Kara M, Harigai M, Suzuki K, Kawaguchi Y, et al. Plasma thrombomodulin and α2-plasmin inhibitor-plasmin complex are elevated in active systemic lupus erythematosus. J Rheumatol 1992;19:1704-9.
16. Kikuchi H, Tanaka S, Matsuo O. Plasminogen activator in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1987;14:439-45.
17. Werb Z, Mainardi CL, Vater CA, Harris ED Jr. Endogenous activation of latent collagenase by rheumatoid synovial cells. N Engl J Med 1977;296:1017-23.
18. de Munk GA, Groeneveld E, Rijken DC. Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin. J Clin Invest 1991;88:1680-4.
19. 3 and activates protein C at their cell membrane. Endocrinol 1993;133:668-74.